Study design

FM Ferenc Emil Mózes
JL Jenny A Lee
ES Emmanuel Anandraj Selvaraj
AJ Arjun Narayan Ajmer Jayaswal
MT Michael Trauner
JB Jerome Boursier
CF Céline Fournier
KS Katharina Staufer
RS Rudolf E Stauber
EB Elisabetta Bugianesi
RY Ramy Younes
SG Silvia Gaia
ML Monica Lupșor-Platon
SP Salvatore Petta
TS Toshihide Shima
TO Takeshi Okanoue
SM Sanjiv Mahadeva
WC Wah-Kheong Chan
PE Peter J Eddowes
GH Gideon M Hirschfield
PN Philip Noel Newsome
VW Vincent Wai-Sun Wong
VL Victor de Ledinghen
JF Jiangao Fan
FS Feng Shen
JC Jeremy F Cobbold
YS Yoshio Sumida
AO Akira Okajima
JS Jörn M Schattenberg
CL Christian Labenz
WK Won Kim
ML Myoung Seok Lee
JW Johannes Wiegand
TK Thomas Karlas
YY Yusuf Yılmaz
GA Guruprasad Padur Aithal
NP Naaventhan Palaniyappan
CC Christophe Cassinotto
SA Sandeep Aggarwal
HG Harshit Garg
GO Geraldine J Ooi
AN Atsushi Nakajima
MY Masato Yoneda
MZ Marianne Ziol
NB Nathalie Barget
AG Andreas Geier
TT Theresa Tuthill
MB M. Julia Brosnan
QA Quentin Mark Anstee
SN Stefan Neubauer
ask Ask a question
Favorite

All study designs were considered if they were reporting on patients with NAFLD undergoing both liver biopsy and LSM-VCTE within 6 months. No language restrictions were applied.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A